michela.roberto@uniroma1.it's picture
Course Code Year Course - Attendance
MEDICAL SURGICAL CLINIC I AND ONCOLOGY 1026419 2021/2022 Medicine and Surgery
MEDICAL SURGICAL CLINIC I AND ONCOLOGY 10596454 2021/2022 Medicine and Surgery
CLINICAL NURSING IN THE PEDIATRIC AREA 1034958 2020/2021 Nursing
NURSING PROCESS AND THERAPEUTIC AREA MEDICAL CARE IN 1047897 2020/2021 Nursing
NURSING PROCESS AND THERAPEUTIC AREA MEDICAL CARE IN 1047897 2020/2021 Nursing
MEDICAL SURGICAL CLINIC I AND ONCOLOGY 1026419 2020/2021 Medicine and Surgery
MEDICAL SURGICAL CLINIC I AND ONCOLOGY 10596454 2020/2021 Medicine and Surgery
MEDICAL SURGICAL CLINIC I AND ONCOLOGY 1026419 2019/2020 Medicine and Surgery
Title Journal Year
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives CANCERS 2021
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients: The new drug-pin® system comprehensive approach PHARMACEUTICALS 2021
The role of opioids in cancer response to immunotherapy JOURNAL OF TRANSLATIONAL MEDICINE 2021
Histological growth patterns and molecular analysis of resected colorectal lung metastases PATHOLOGY RESEARCH AND PRACTICE 2021
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer CURRENT ONCOLOGY 2021
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice FRONTIERS IN ONCOLOGY 2021
In vivo imaging-based techniques for early diagnosis of oral potentially malignant disorders—systematic review and meta-analysis INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma ENDOCRINE 2020
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma ENDOCRINE 2020
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2020
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification ANNALS OF ONCOLOGY 2020
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL VACCINES 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 FRONTIERS IN IMMUNOLOGY 2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience ANTI-CANCER DRUGS 2020
Tissue immune profile: a tool to predict response to neoadjuvant therapy in triple negative breast cancer CANCERS 2020
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial CANCERS 2020
Gynecological and reproductive factors and the risk of pancreatic cancer. a case-control study PANCREATOLOGY 2020
Evaluation of prognostic factors for survival in transverse colon cancer CANCERS 2020
Risk of coronavirus disease 2019 in patients treated for cancer. An immune response–based hypothesis EUROPEAN JOURNAL OF CANCER 2020
Department
SSD